Title compds. [I; X = CH, N; R = H, alkylthio, alkylamino, cycloalkyl, cycloalkylthio, cycloalkylamino, alkyl, etc.; R1 = NHR6, N(R6)2; R6 = alkyl, cycloalkyl, pyrrolidinyl, morpholino, hexahydroazepinyl, (substituted) (hetero)aryl(alkyl)], were prepd. Thus, title compd. (II) (multistep prepn. outlined) after 48 h reduced cellular viability of SaOS-2 cells to 15.1% of controls.
Preparation of pyrazolo[3,4-d]pyrimidines and pyrrolo[2,3-d]pyrimidines for treatment of bone related diseases and tumors.
SCHENONE, SILVIA;BONDAVALLI, FRANCESCO;BRUNO, OLGA;
2009-01-01
Abstract
Title compds. [I; X = CH, N; R = H, alkylthio, alkylamino, cycloalkyl, cycloalkylthio, cycloalkylamino, alkyl, etc.; R1 = NHR6, N(R6)2; R6 = alkyl, cycloalkyl, pyrrolidinyl, morpholino, hexahydroazepinyl, (substituted) (hetero)aryl(alkyl)], were prepd. Thus, title compd. (II) (multistep prepn. outlined) after 48 h reduced cellular viability of SaOS-2 cells to 15.1% of controls.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
